The American Society of Clinical Oncology (ASCO) is set to honor individuals who have consistently worked towards making tremendous advancements in the field of cancer. Among those being rewarded for their lifetime commitment to improving the lives of people living with cancer are Dr. Jordan, the first scientist to demonstrate tamoxifen’s effectiveness in the prevention of breast cancer, and Mary-Claire King, who was the first to provide proof of the genetic inheritance of breast cancer.